Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…
-
EMA withdrawal · 2019-03-05EMA Withdrawn: Solymbic (adalimumab) — Amgen Europe B.V.
Solymbic (adalimumab) has been withdrawn from the market by Amgen Europe B.V.
-
FDA approval · 2019-02-21FDA Approved: PREDNISONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for prednisone from Mylan Pharmaceuticals, indicating approval of an existing generic product's …
-
CLINICAL_TRIALS research · 2019-02-18Clinical Trial Update: A Trial for Prevention of Loss of the Effect of Biological Drugs in Patients With Inflammatory Bowel Disease [NA]
Clinical trial update on preventing loss of response to biological drugs in inflammatory bowel disease; no results or status details are pro…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease [NA]
Clinical trial update for a web-based monitoring intervention in children and adolescents with inflammatory bowel disease; status completed …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis
A clinical trial update describing a study that measures endoscopic activity in ulcerative colitis patients treated with vedolizumab.
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases
This clinical trial update explores a potential link between bilirubin metabolism, gut microbiota, and inflammatory bowel diseases, includin…
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases [NA]
A terminated clinical trial update from University Hospital Lille evaluating two therapeutic strategies for inflammatory bowel diseases; no …
-
CLINICAL_TRIALS research · 2019-02-12Clinical Trial Update: Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC [Phase 3]
This Phase 3 clinical trial compares fecal microbiota therapy with 5-aminosalicylates for induction of remission in newly diagnosed mild-to-…
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy [Phase 2]
Phase 2 trial update evaluating methylene blue MMX tablets to detect neoplasia during colonoscopy in patients with ulcerative colitis; resul…
-
CLINICAL_TRIALS research · 2019-02-07Clinical Trial Update: Fecal Calprotectin Collection Protocol
This clinical trial update outlines the fecal calprotectin collection protocol used in a completed trial sponsored by DiaSorin.
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Proteomic Analysis of Crohn's Disease Macrophages in Response or Not to AIEC
The completed trial analyzed the proteomic profile of macrophages from Crohn's disease patients to assess their response to AIEC bacteria, w…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis
This completed clinical trial evaluates the value of chromoendoscopy as a surveillance strategy for detecting dysplasia in patients with Ulc…
-
CLINICAL_TRIALS research · 2019-01-31Clinical Trial Update: Multimodal Approach in IBD Patients
This clinical trial update describes a multimodal approach in inflammatory bowel disease patients, including ulcerative colitis and Crohn's …
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers [Phase 1]
Phase 1 multiple-dose safety and tolerability study of BMS-986166 in healthy volunteers; Ulcerative Colitis is listed as the associated cond…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Pediatric FEcal Microbiota Transplant for Ulcerative Colitis [Phase 1]
A Phase 1 pediatric trial evaluating fecal microbiota transplantation for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
This clinical trial update reports on patient adherence attitudes toward scheduled adalimumab maintenance therapy across multiple inflammato…
-
FDA approval · 2019-01-25FDA Approved: MESALAMINE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's generic Mesalamine as an original ANDA application.
-
CLINICAL_TRIALS research · 2019-01-16Clinical Trial Update: Fecal Microbiota Transplantation and Analysis of Fecal Microbiome in IBD Patients [NA]
This clinical trial update from Yonsei University concerns fecal microbiota transplantation and analysis of the fecal microbiome in patients…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Fecal Microbiota Transplantation for Ulcerative Colitis [Phase 2, Phase 3]
A clinical trial update for fecal microbiota transplantation in ulcerative colitis is listed as phase 2 and phase 3 and currently recruiting…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update for Lactobacillus reuteri ATCC PTA 4659 in Ulcerative Colitis flare.
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update for JNJ-54781532 in moderately to severely active ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC [Phase 2]
Phase 2 clinical trial of GED-0507-34-Levo for ulcerative colitis was terminated, with results posted.
-
FDA approval · 2018-10-30FDA Approved: ADALIMUMAB — Original Application (Sandoz Inc)
FDA approved the original application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc. The approval covers the same indication…
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis [Phase 2]
Phase 2 trial update on apremilast for active ulcerative colitis reports efficacy and safety findings. The study is completed with results p…